Mode
Text Size
Log in / Sign up
N/A N=24 Other

Parent-Adolescent Training on Neurofeedback and Synchrony

Testing Protocol With Healthy Individuals for Feasibility

Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Neurofeedback Rating Scale — 5.7 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Real-time fMRI neurofeedback (Behavioral)
Age
Pediatric, Adult, Older Adult · 13+ yrs
Sex
Female
Sponsor
Oklahoma State University Center for Health Sciences
Primary completion
Feb 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Neurofeedback Rating Scale
5.7
PRIMARY
Emotion Rating Scale
2.11
PRIMARY
Blood Oxygen Level-Dependent (BOLD) Signal Changes (Brain Activation)
0.15

Summary

The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.

Eligibility Criteria

Inclusion Criteria

  • Eligible for fMRI
  • Sufficient English fluency to complete tasks
  • BMI ≦ 40.0
  • Right-handed
  • Biological female
  • Co-residing at least 4 days/week
  • Adult participants: Biological mother of adolescent participant
  • Adult participants: Primary caregiver > 50% of child's lifespan
  • Adult participants:BMI ≧ 18.0
  • Adolescent participants: Age 13-17 years
  • Adolescent participants: BMI ≧ 16.0

Exclusion Criteria

  • Current psychiatric diagnosis
  • Medications influencing fMRI
  • Medical conditions influencing fMRI
  • Alcohol or psychoactive drug on scan day
  • Adolescent participants: Neurodevelopmental delay
  • Adolescent participants: History of mood or psychotic disorder
  • Adolescent participants: History of obsessive-compulsive disorder (OCD) or attention-deficit/hyperactivity disorder (ADHD)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03929263). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search